DeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough
Inspired Chemistry™ platform eliminates manual chemical synthesis as a key bottleneck in drug discovery with automated high-throughput, multi-step synthesis to... Read more.
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis
The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class... Read more.
Aramark to Participate in Upcoming Investor Conferences
PHILADELPHIA–(BUSINESS WIRE)–Aramark (NYSE:ARMK), a global leader in food and facilities management, announced that members of its executive management... Read more.
Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Oral presentation to highlight safety and preliminary efficacy of EIK1001 in combination with pembrolizumab Separate poster presentations will highlight EIK1001... Read more.
VSE Corporation Announces June 2024 Investor Conference Schedule
ALEXANDRIA, Va.–(BUSINESS WIRE)–VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aftermarket distribution and repair... Read more.
Danaos Corporation Reports First Quarter Results for Period Ended March 31, 2024
ATHENS, Greece–(BUSINESS WIRE)–Danaos Corporation (“Danaos”) (NYSE: DAC), one of the world’s largest independent owners of container vessels and... Read more.
Consensus Cloud Solutions to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference in June 2024
LOS ANGELES–(BUSINESS WIRE)–Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today announced its participation at the Goldman Sachs 45th Annual Global... Read more.
Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
First patient dosed with AFNT-211 targeting KRAS G12V oncogene mutation in solid tumors Trial-in-progress poster to be presented on June 3rd at the 2024 ASCO Annual... Read more.
MultiBank Group Receives “Best Global Forex Broker” Award at Forex Traders Summit Dubai 2024
DUBAI, United Arab Emirates–(BUSINESS WIRE)–MultiBank Group, a leading forex broker, has achieved a significant milestone by clinching the prestigious... Read more.
Hopewind on Bloomberg New Energy Finance Tier 1 List and Only Chinese Inverter Company on Intersolar / Smarter E Award Short-list
ALMERE, Netherlands–(BUSINESS WIRE)–Hopewind (SHANGHAI STOCK EXCHANGE Code: 603063) has been officially nominated for the 2024 Smarter E award for its... Read more.